Jobs
View more job listings or post a job
Gilead Sciences Senior Research Associate, Drug Metabolism
Gilead Sciences Research Scientist, Drug Metabolism
Gilead Sciences Principal Scientist, Drug Metabolism
Gilead Sciences Research Scientist, Drug Metabolism
Theravance Biopharma Associate Scientist
Gilead Sciences Associate Scientist (Contractor)
Evotec/Genentech Contractor Scientific Researcher/Sr. Scientific Researcher in Protein Chemistry
Evotec/Genentech Contractor Scientific Researcher/Sr. Scientific Researcher in Protein Chemistry
Applied Photophysics Application Scientist
Genentech Associate Scientist(Contract)
Post a job

Symposium

Tox 21 and New Approach Methodology (NAMs): Using Emerging Technologies to Improve Translational Research and Safety Assessment Predictions (jointly by SOT-NorCal & PBSS)


Speakers: Kathryn Page (Clorox); Shichang Miao (ChemoCentryx); Thomas Hartung (The Bloomberg School of Public Health); Emily Reinke (U.S. Army Public Health Center); Suzanne Fitzpatrick (FDA); Pamela Lein (UC Davis); Ellen Berg (Eurofins); Will Proctor (Genentech)
Organizers:
Date: 4/25/2019
Time: 8:30-17:00
Registration fee (USD): Regular (with lunch): $60; Students & Postdocs (with lunch): $0;
Location: South San Francisco Conference Center
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:4/23/2019  (it will close sooner if the seating cap is reached)

About the Topic

Preliminary Agenda

Morning Session

7:30 am – 8:30 am          Registration & Breakfast

8:30 am – 8:45 am          Opening message from The NorCal & PBSS Presidents - Kathryn Page, PhD, DABT, Clorox; Shichang Miao, PhD, ChemoCentryx

8:45 am – 9:30 am          Plenary Speaker:  Alternative Methods for the 21st Century - Thomas Hartung, PhD, Johns Hopkins Bloomberg School of Public Health

9:30 am – 10:15 am        From Experimental Concept to Regulatory Acceptance:  The Success of Alternative Methods in Skin Sensitization Testing - Emily Reinke, PhD, DABT, U.S. Army Public Health Center

10:15 am – 10:30 am     Coffee Break

10:30 am – 11:15 am     Consumer Product Safety Assessment: An Alternative Approach - Kathryn Page, PhD, DABT, Clorox

11:15 am – 12:00 pm     Predictive Toxicology for Regulatory Decisions:  Implementing New Approaches at FDA - Suzanne Fitzpatrick, PhD, FDA

12:00 pm – 1:30 pm       Lunch Break: Lunch with Experts, Posters

Afternoon Session

1:30 pm – 1:45 pm         Chapter announcements and acknowledgements

1:45 am – 2:05 am          NorCal Student Award presentation: TBD

2:05 pm – 2:45 pm         In Vitro and Alternative Models of Neurotoxicity:  Opportunities and Challenges for Neurotoxicity Testing - Pamela Lein, PhD, DABT, UC Davis

2:45 pm – 3:00 pm         Coffee Break

3:00 pm – 3:45 pm         Applying Human-based Phenotypic Profiling in Early Drug Discovery - Ellen Berg, PhD, Eurofins

3:45 pm – 4:30 pm         Industry Perspective on Evaluating, Qualifying, and Implementing Complex In Vitro Models to Support Drug Discovery - Will Proctor, PhD, DABT, Genentech

4:30 pm – 6:00 pm         Reception & Networking


2019-03-07, Promising Therapeutic Approaches and Translational Medicine to Advance Novel Therapeutics (A Joint Symposium by PBSS and Stanford SPARK Program)
2019-03-11, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2019-05-06, CMC Development for Biologics: Purification, Formulation, Analytical Characterization, Production Systems, Regulatory and Product Development
2019-06-11, Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)
2019-09-13, Biotransformation and Disposition of Larger Molecules: Peptides, Nucleotides, Proteins, mAbs, and ADCs
2019-10-03, Bioanalytical Method Validation & Regulated Bioanalysis: Fundamentals, the New FDA Guidance and Regulatory Trends
┬ęPharmaceutical & BioScience Society, International; Last Modified: 2/23/2019; Visited: 460; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Submit a Text Ad